DANVERS, Mass. (BUSINESS WIRE) Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, April 28, 2022, the Company will release financial results for the fourth quarter of the fiscal year 2022. The Company will host a conference call to discuss the results on Thursday, April 28, 2022 at 8:00 a.m. ET. Michael R. M.
DANVERS, Mass. (BUSINESS WIRE) Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference (virtual) on Th.
Regulators in three countries have granted approvals to Impella surgical products, as Abiomed continues to execute its strategy for sustainable growth with new products, new indications and new. | January 10, 2022
ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.